Skip to main content Accessibility Statement

News Release Details

Tactile Medical to Participate in the Oppenheimer Healthcare Conference

March 7, 2022

MINNEAPOLIS, March 07, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that management will participate in Oppenheimer’s 32nd Annual Healthcare Conference, which is being held virtually from March 15th-16th. Management will participate in a virtual fireside chat on Tuesday, March 15th at 3:20 p.m. Eastern Time and host virtual 1x1 meetings on Wednesday, March 16th.

A live audio webcast of the fireside chat will be accessible under the “Events & Webcasts” section of the Company's investor relations website at An archive of the webcast will be available for replay following the conference.

About Tactile Medical

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.

Investor Inquiries:

Mike Piccinino, CFA
Managing Director
ICR Westwicke[email protected]

Primary Logo

Source: Tactile Systems Technology, Inc.